To assess the contribution of neurodegeneration to the differences in CSF PINK1 levels between AD and controls, we included CSF levels of neurofilament light chain (NEFL), a biomarker of neurodegeneration, as a covariate in the ANCOVA analyzes. This evidence concerns the gene NEFL and Alzheimer disease.